title: Biological activity of EDQM CRS for Interferon alfa-2a and Interferon alfa-2b - assessment in two in vitro bioassays.
abstract: The European Directorate for the Quality of Medicines (EDQM) supplies Chemical Reference Substances (CRS) for Interferon (IFN) alfa-2a (CRS I0320300) and for IFN alfa-2b (CRS I0320301) for specified physicochemical tests. However, no information is provided as to their biological activity. In contrast, the World Health Organization (WHO) provides the 2nd International Standards (IS) for IFN alfa-2a (code 95/650) and for IFN alfa-2b (code 95/566), with activity defined in International Units (IU) for calibration of biological activity of preparations of IFN. We have compared the EDQM CRSs with the WHO ISs in two bioassay systems, one measuring the anti-proliferative activity in the Daudi cell line and the other measuring a reporter gene activation in an A549 cell line. In each of these assay systems, the CRSs gave dose - response relations, which were similar to those for the WHO ISs. Estimates of relative activity for each CRS, in terms of the respective IS, showed specific biological activity for the CRSs of the same order as the nominal specific activity for the ISs. However, the estimates of relative activity were not consistent between the two assays systems, emphasizing the need for calibration within each system, if the CRS were to be used as a working standard for bioassays. For structure-activity studies, both physicochemical and biological activity characterisation are required for the same biopharmaceutical preparation. CRS I0320300 and CRS I0320301 may prove useful as working standards for some bioassay systems.
authors.affiliation: Institute for Biological Standards & Control, Blanche Lane, South Mimms, Hertfordshire, EN6 3QG, United Kingdom. msilva@nibsc.ac.uk
authors.forename: M M C G
authors.initials: MM
authors.lastname: Silva
authors.forename: R E
authors.initials: RE
authors.lastname: Gaines-Das
authors.forename: C
authors.initials: C
authors.lastname: Jones
authors.forename: C J
authors.initials: CJ
authors.lastname: Robinson
mesh_terms: D000970:Antineoplastic Agents / Q000032:analysis* / Q000494:pharmacology / Q000592:standards*; D001681:Biological Assay; D002138:Calibration; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004305:Dose-Response Relationship, Drug; D005060:Europe; D017930:Genes, Reporter / Q000187:drug effects; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000032:analysis* / Q000494:pharmacology / Q000592:standards*; D008156:Luciferases / Q000235:genetics; D011994:Recombinant Proteins; D012015:Reference Standards
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D008156:Luciferases